Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

24 terminated/withdrawn out of 430 trials

Success Rate

90.4%

+3.8% vs industry average

Late-Stage Pipeline

9%

40 trials in Phase 3/4

Results Transparency

1%

3 of 226 completed trials have results

Key Signals

63 recruiting3 with results15 terminated9 withdrawn

Enrollment Performance

Analytics

N/A
192(67.1%)
Phase 2
38(13.3%)
Phase 4
26(9.1%)
Phase 1
15(5.2%)
Phase 3
14(4.9%)
Early Phase 1
1(0.3%)
286Total
N/A(192)
Phase 2(38)
Phase 4(26)
Phase 1(15)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (430)

Showing 20 of 430 trials
NCT04943926Not ApplicableActive Not Recruiting

Dietary Strategies for Remission of Type 2 Diabetes

Role: collaborator

NCT07851493Recruiting

Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise)

Role: lead

NCT07108049Not ApplicableActive Not Recruiting

Strengthening Relationships and Mental Health Through a Couples-Based Economic Empowerment Intervention

Role: lead

NCT06650995Not ApplicableRecruiting

AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure

Role: lead

NCT07777575Phase 4Recruiting

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Role: lead

NCT05983588Phase 2Completed

PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)

Role: lead

NCT07647471Not ApplicableRecruiting

Evaluation of an Exercise Intervention During Intensive Medical Treatment in Pediatric Oncology.

Role: collaborator

NCT05931575Phase 2Completed

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Role: lead

NCT05665101Not ApplicableActive Not Recruiting

EndoVascular Aortic Repair With Sac Embolization for the Prevention of Type II Endoleaks (the EVAR-SE Study)

Role: collaborator

NCT05261256Completed

Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

Role: lead

NCT05235633Enrolling By Invitation

ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma

Role: lead

NCT06737172Active Not Recruiting

Functional and Structural Outcomes Following Childhood Bone or Soft Tissue Sarcomas of the Lower Extremity

Role: lead

NCT06743958Not ApplicableActive Not Recruiting

Prehabilitation in Childhood Soft Tissue or Bone Sarcomas

Role: lead

NCT07743021Recruiting

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

Role: collaborator

NCT07734961Not ApplicableActive Not Recruiting

Gender-Transformative Interventions and Normative Beliefs About Reproductive Decision-Making

Role: lead

NCT07727005Not ApplicableNot Yet Recruiting

Effectiveness of Clustered Versus Tapered Repetitive Transcranial Magnetic Stimulation (rTMS) as Maintenance Therapy Following Successful Acute rTMS Treatment in Patients With Depressive Syndrome

Role: lead

NCT07726420Not ApplicableRecruiting

HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin

Role: lead

NCT07721766Not ApplicableRecruiting

Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training

Role: lead

NCT07213440Not ApplicableRecruiting

Identification of Early Markers for ALS

Role: collaborator

NCT07613957Not ApplicableNot Yet Recruiting

Comparison of AI-based Smartphone-derived Gait Parameters With the Gold Standard

Role: lead